ARCHIVES

Funding opportunities listed.

This article is from The Cancer Letter archive.

Vol. 30 No. 30 | July 23, 2004

Download PDF Visit The Full Archive

Related Articles

PET Three Months After Therapy Provides Early Warning Of Need For Intervention

November 30, 2007

Neratinib Graduates from I-SPY Phase II Adaptive Trial Regimen

April 25, 2014

Importation Is Remedy of Last Resort in Effort to Obtain Generic Injectables

March 2, 2012

Chop Analysis Shows Program Had Major Impact In Communities

January 25, 1985

Clinical Trials Approved By NCI CTEP Last Month

May 27, 2011

Conversation with The Cancer Letter: IU’s Loehrer Discusses “Business Decision” To Close Bloomington Proton Beam Center

October 17, 2014